Gram Research analysis of a 2026 systematic review found that cricopharyngeal myotomy, a surgery that opens the throat muscle, worked best for swallowing problems in oculopharyngeal muscular dystrophy, succeeding in about 91% of patients and lasting about 6 years. Botulinum toxin and esophageal dilation were less invasive but needed repeat treatments.
Swallowing trouble is one of the first and most serious problems for people with oculopharyngeal muscular dystrophy, a rare inherited disease that slowly weakens the muscles of the throat and eyelids. Gram Research analysis of a systematic review, which examined 40 studies covering 464 treated patients, compared three treatments. Surgery to loosen a tight throat muscle, called cricopharyngeal myotomy, helped about 91% of patients, and its benefits lasted a median of about 6 years, although it is the most invasive option. Stretching the esophagus, called esophageal dilation, helped about 71% of patients for about 16 months, with very few complications. Botulinum toxin injections, which relax muscles, helped about 59% of patients for roughly 6 months, and nearly half of patients had side effects. The authors note that people with severe throat weakness may need softer diets or a feeding tube.
Key Statistics
A 2026 systematic review of 40 studies found that cricopharyngeal myotomy, a surgery for swallowing problems in oculopharyngeal muscular dystrophy, succeeded in about 91% of the 405 patients whose outcomes were reported.
The same systematic review found that the benefits of esophageal dilation lasted a median of about 16 months, compared with about 6 months for botulinum toxin injections.
A 2026 systematic review reported complications in less than 1% of patients receiving esophageal dilation, compared with about 44% of patients receiving botulinum toxin injections.
The Quick Take
- What they studied: Researchers wanted to know which treatment for swallowing problems in oculopharyngeal muscular dystrophy works best, how long its effects last, and how often it causes complications.
- Who participated: The review did not enroll new people. It combined results from 40 published studies that described adults with this disease. Across the three treatments, outcomes were reported for 28 people receiving botulinum toxin, 31 receiving esophageal dilation, and 405 receiving throat muscle surgery.
- Key finding: Throat muscle surgery (cricopharyngeal myotomy) helped the most, with about 91% of patients improving and benefits lasting a median of about 6 years. Esophageal dilation helped about 71% of patients for about 16 months, and botulinum toxin helped about 59% of patients for about 6 months.
- What it means for you: If you or a loved one has this condition, these results suggest that surgery may offer the longest-lasting relief, while less invasive options may help early on but often need to be repeated. Any treatment choice should be made with a swallowing specialist who knows your individual case.
The Research Details
A systematic review is a way of gathering all the published research on a question, then judging the results together. The authors searched six large medical databases for studies, published from the start of each database through November 5, 2025, that reported what happened to adults with this disease after one of three swallowing treatments. They registered their plan in advance in a public registry (PROSPERO, CRD42025575703), which helps prevent changes to the plan after the results are known.
Out of 2,920 article titles found by the search, 40 met the rules for inclusion. The researchers then pulled out the treatment success rates, complication rates, and how long the benefits lasted. Because the studies were different from one another in design and patient groups, the results were summarized in a descriptive way rather than combined into one single statistic.
The study does not test a new treatment itself. Instead, it asks what the existing published evidence shows, and it points out where that evidence is thin.
Many people with this disease are never given a clear comparison of their options, and individual studies are often too small to show a full picture. Pulling together all the available studies helps doctors and patients see patterns that a single small study could miss, such as how long each treatment lasts and how often problems occur.
The review followed a pre-registered plan and searched several major databases, which are strengths. However, the studies it included were likely small, and most were probably observational reports rather than large randomized trials, so the numbers should be treated as rough estimates. The total sample size is not stated in the report, and the patient counts for each treatment come from different studies that may have overlapped. The authors’ own conclusions are based on the best available evidence, which appears limited for this rare disease.
What the Results Show
Throat muscle surgery (cricopharyngeal myotomy) had the highest success rate, at about 91% across 405 patients. It is also the most invasive option. Its benefits lasted a median of about 6 years, which means that for many people the improvement was long-lasting. The review describes this surgery as leading to the most complete improvement in swallowing, though the authors also caution that people with severe throat weakness were more likely to have poor results.
Esophageal dilation, which gently stretches the tube that carries food to the stomach, helped about 71% of 31 patients. Its effects lasted a median of about 16 months. Complications were very rare, occurring in less than 1% of patients. This makes it a less invasive choice than surgery, though it still needs to be repeated over time.
Botulinum toxin injections, which temporarily relax the throat muscle, helped about 59% of 28 patients. The benefits lasted about 6 months, so repeat injections are usually needed. Complications were more common, affecting about 44% of patients. The authors describe botulinum toxin and dilation as helpful for early symptoms but typically needing ongoing treatment.
The authors noted that when throat weakness was severe, surgery did not work as well, and people in that situation may need other options. These include changing to a modified diet, such as softer or thicker foods, or using a feeding tube (gastrostomy tube) to make sure they get enough nutrition. These findings matter because they show that treatment is not one-size-fits-all, and that protecting nutrition and hydration is a key goal in every case.
The review compares these three treatments side by side, which had not been done in one place before for this rare disease. Earlier reports on each treatment were mostly individual case series or small studies. The review’s findings fit with what is known about swallowing treatments in other muscle and nerve conditions: surgery that opens the throat muscle tends to last longer than injections that relax it, while injections are easier to try first.
The biggest limitation is that the evidence comes from a small number of studies, with only 28 to 405 patients per treatment, and the review does not say how many people were involved overall. Most of these studies were likely not randomized trials, meaning patients were not randomly assigned to different treatments, so the groups may have differed in ways that affected the results. Outcomes may also have been measured differently from study to study. The review cannot prove that one treatment is better than another, only that the reported results differ. The review was also limited to studies published in certain languages and databases, and results from unpublished studies were not included.
The Bottom Line
Research suggests that throat muscle surgery (cricopharyngeal myotomy) offers the most lasting relief for swallowing problems in this disease, with a success rate of about 91%, though confidence in these numbers is moderate because the evidence comes from small studies. Esophageal dilation appears to be a safer, less invasive option with a longer effect than botulinum toxin, though confidence is also moderate. Botulinum toxin may help early symptoms, but its effects are short and complications are common, so confidence in its use as a long-term solution is lower. Patients with severe throat weakness may need diet changes or a feeding tube, and this should be discussed early with a care team.
This research is most relevant to adults with oculopharyngeal muscular dystrophy, their families, and the doctors, speech-language pathologists, and dietitians who care for them. It is less relevant to people without this condition, since the results do not apply to other causes of swallowing trouble. Anyone considering a procedure should talk with a specialist about their own health, muscle strength, and goals before making a decision.
Benefits differ by treatment. Botulinum toxin injections typically work within days to weeks but wear off after about 6 months, so repeat injections are often needed. Esophageal dilation may bring improvement soon after treatment and lasts about 16 months on average. Throat muscle surgery may take longer to show its full effect, but its benefits last a median of about 6 years. Individual results vary widely, and the review did not measure timelines in detail.
Frequently Asked Questions
What is the best treatment for swallowing problems in oculopharyngeal muscular dystrophy?
Research reviewed in a 2026 systematic review found that cricopharyngeal myotomy, a throat muscle surgery, had the highest success rate at about 91% and the longest benefits, lasting a median of about 6 years. It is also the most invasive option, so it requires careful discussion with a specialist.
How long do botulinum toxin injections last for swallowing problems?
According to research reviewed by Gram, botulinum toxin injections for swallowing trouble in this muscle disease helped about 59% of patients, with effects lasting a median of about 6 months. Because the benefit wears off, repeat injections are usually needed.
Is esophageal dilation safe for people with muscular dystrophy?
A systematic review found that esophageal dilation, which gently stretches the esophagus, caused complications in less than 1% of patients. It helped about 71% of patients, with benefits lasting a median of about 16 months, though studies were small and results should be discussed with a doctor.
What should people with severe swallowing weakness do if surgery is not an option?
Research suggests that people with severe throat weakness may get poorer results from throat surgery and may need other approaches. These can include a modified diet with softer or thicker foods, or a feeding tube (gastrostomy tube) to make sure they get enough nutrition and fluids.
Want to Apply This Research?
- Log each meal and drink once a day, and rate how easily you swallowed on a simple 1 to 5 scale, with 1 being very hard and 5 being easy. Also note any coughing, choking, or throat clearing during meals, and how many times it happened. Tracking these numbers over several weeks can show whether swallowing is improving, staying the same, or getting worse.
- Use the app to set reminders for swallowing exercises or diet changes your care team recommends, such as eating smaller bites, sitting upright during meals, or choosing softer foods. Check off each reminder when completed so you can see patterns over time and bring that record to your next appointment.
- Review your swallowing log every month and share the trends with your doctor or speech-language pathologist at regular visits. Watch for signs that treatment is wearing off, such as more frequent coughing with meals or a drop in your daily rating, and report them promptly. Over time, these records can help your care team decide when to repeat a treatment or consider other options, such as a feeding tube.
This article summarizes a systematic review of published studies on treatments for swallowing problems in oculopharyngeal muscular dystrophy. It is for general education only and is not medical advice. The evidence comes from small, mostly observational studies, so results may not apply to everyone. Talk with your doctor, neurologist, or speech-language pathologist before making any decisions about treatment, diet, or feeding.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.